These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15517832)

  • 1. Acanthosis nigricans in a boy with achondroplasia due to the classical Gly380Arg mutation in FGFR3.
    Van Esch H; Fryns JE
    Genet Couns; 2004; 15(3):375-7. PubMed ID: 15517832
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gly380Arg and Asn540Lys mutations of fibroblast growth factor receptor 3 in achondroplasia and hypochndroplasia in the Spanish population].
    Ezquieta Zubicaray B; Iguacel AO; Varela Junquera JM; Jariego Fente CM; González Gancedo P; Gracia Bouthelier R
    Med Clin (Barc); 1999 Mar; 112(8):290-3. PubMed ID: 10207844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
    Meyers GA; Orlow SJ; Munro IR; Przylepa KA; Jabs EW
    Nat Genet; 1995 Dec; 11(4):462-4. PubMed ID: 7493034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.
    Vajo Z; Francomano CA; Wilkin DJ
    Endocr Rev; 2000 Feb; 21(1):23-39. PubMed ID: 10696568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achondroplasia with the FGFR3 1138g-->a (G380R) mutation in two sibs sharing a 4p haplotype derived from their unaffected father.
    Sobetzko D; Braga S; Rüdeberg A; Superti-Furga A
    J Med Genet; 2000 Dec; 37(12):958-9. PubMed ID: 11186940
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene.
    Tavormina PL; Bellus GA; Webster MK; Bamshad MJ; Fraley AE; McIntosh I; Szabo J; Jiang W; Jabs EW; Wilcox WR; Wasmuth JJ; Donoghue DJ; Thompson LM; Francomano CA
    Am J Hum Genet; 1999 Mar; 64(3):722-31. PubMed ID: 10053006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtle radiographic findings of achondroplasia in patients with Crouzon syndrome with acanthosis nigricans due to an Ala391Glu substitution in FGFR3.
    Schweitzer DN; Graham JM; Lachman RS; Jabs EW; Okajima K; Przylepa KA; Shanske A; Chen K; Neidich JA; Wilcox WR
    Am J Med Genet; 2001 Jan; 98(1):75-91. PubMed ID: 11426459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achondroplasia in Turkey is defined by recurrent G380R mutation of the FGFR3 gene.
    Pehlivan S; Ozkinay F; Okutman O; Coğulu O; Ozcan A; Cankaya T; Ulgenalp A
    Turk J Pediatr; 2003; 45(2):99-101. PubMed ID: 12921294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved methodology for the detection of the common mutation in the FGFR3 gene responsible for achondroplasia.
    Lanning RW; Brown CA
    Hum Mutat; 1997; 10(6):496-9. PubMed ID: 9401015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice.
    Iwata T; Li CL; Deng CX; Francomano CA
    Hum Mol Genet; 2001 Jun; 10(12):1255-64. PubMed ID: 11406607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominance of the mutation at 1138 of the cDNA for the fibroblast growth factor receptor 3 in Japanese patients with achondroplasia.
    Tonoki H; Nakae J; Tajima T; Shinohara N; Monji J; Satoh S; Fujieda K
    Jpn J Hum Genet; 1995 Dec; 40(4):347-9. PubMed ID: 8851771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation.
    Couser NL; Pande CK; Turcott CM; Spector EB; Aylsworth AS; Powell CM
    Am J Med Genet A; 2017 Apr; 173(4):1097-1101. PubMed ID: 28181399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGFR3 gene mutation (Gly380Arg) with achondroplasia and i(21q) Down syndrome: phenotype-genotype correlation.
    Chen H; Mu X; Sonoda T; Kim KC; Dailey K; Martinez J; Tuck-Muller C; Wertelecki W
    South Med J; 2000 Jun; 93(6):622-4. PubMed ID: 10881785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia.
    Bellus GA; McIntosh I; Smith EA; Aylsworth AS; Kaitila I; Horton WA; Greenhaw GA; Hecht JT; Francomano CA
    Nat Genet; 1995 Jul; 10(3):357-9. PubMed ID: 7670477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and molecular characteristics of Thai patients with achondroplasia.
    Shotelersuk V; Ittiwut C; Srivuthana S; Wacharasindhu S; Aroonparkmongkol S; Mutirangura A; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2001 Jun; 32(2):429-33. PubMed ID: 11556601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recurrent mutation, ala391glu, in the transmembrane region of FGFR3 causes Crouzon syndrome and acanthosis nigricans.
    Wilkes D; Rutland P; Pulleyn LJ; Reardon W; Moss C; Ellis JP; Winter RM; Malcolm S
    J Med Genet; 1996 Sep; 33(9):744-8. PubMed ID: 8880573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the fibroblast growth factor receptor 3 (FGFR3) cause achondroplasia, hypochondroplasia, and thanatophoric dysplasia: Taiwanese data.
    Tsai FJ; Tsai CH; Chang JG; Wu JY
    Am J Med Genet; 1999 Sep; 86(3):300-1. PubMed ID: 10482885
    [No Abstract]   [Full Text] [Related]  

  • 18. Achondroplasia is defined by recurrent G380R mutations of FGFR3.
    Bellus GA; Hefferon TW; Ortiz de Luna RI; Hecht JT; Horton WA; Machado M; Kaitila I; McIntosh I; Francomano CA
    Am J Hum Genet; 1995 Feb; 56(2):368-73. PubMed ID: 7847369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3.
    Bellus GA; Bamshad MJ; Przylepa KA; Dorst J; Lee RR; Hurko O; Jabs EW; Curry CJ; Wilcox WR; Lachman RS; Rimoin DL; Francomano CA
    Am J Med Genet; 1999 Jul; 85(1):53-65. PubMed ID: 10377013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mutation analysis of fibroblast growth factor receptor 3 gene in an achondroplasia family].
    Zhu B; Dong QM; Huang XH; Ji GQ; Chen Y; Wang WX; Jiang HY; Gao JS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):373-5. PubMed ID: 14556186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.